A heated debate in drug policy concerns the relative merits of "harm reduction" (e.g., reducing drug-related HIV/AIDS transmission) vs. "use reduction" (controlling drug use per se). This paper models whether shifting emphasis between these goals over the course of a drug epidemic might reduce...